{"id":74534,"date":"2023-09-01T20:39:37","date_gmt":"2023-09-01T15:09:37","guid":{"rendered":"http:\/\/finservwealth.com\/saroja-pharma-industries-ipo-booked-2-01-times-on-day-2\/"},"modified":"2023-09-01T20:39:37","modified_gmt":"2023-09-01T15:09:37","slug":"saroja-pharma-industries-ipo-booked-2-01-times-on-day-2","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/saroja-pharma-industries-ipo-booked-2-01-times-on-day-2\/","title":{"rendered":"Saroja Pharma Industries IPO booked 2.01 times on day 2"},"content":{"rendered":"<p> Saroja Pharma Industries IPO: Retail investors lent good support to the IPO and subscribed for 18.81 lakh shares, which was 3.65 times their reserved portion, while the part set aside for HNIs was subscribed by 57 percent<\/p><div id=\"finse-58700581\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/saroja-pharma-industries-ipo-booked-201-timesday-2_17226191.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Saroja Pharma Industries IPO: Retail investors lent good support to the IPO and subscribed for 18.81 lakh shares, which was 3.65 times their reserved portion, while the part set aside for HNIs was subscribed by 57 percent Saroja Pharma Industries IPO: Retail investors lent good support to the IPO and subscribed for 18.81 lakh shares, which was 3.65 times their reserved portion, while the part set aside for HNIs was subscribed by 57 percent\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/saroja-pharma-industries-ipo-booked-201-timesday-2_17226191.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Saroja Pharma Industries IPO: Retail investors lent good support to the IPO and subscribed for 18.81 lakh shares, which was 3.65 times their reserved portion, while the part set aside for HNIs was subscribed by 57 percent<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/saroja-pharma-industries-ipo-booked-201-timesday-2_17226191.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Saroja Pharma Industries IPO: Retail investors lent good support to the IPO and subscribed for 18.81 lakh shares, which was 3.65 times their reserved portion, while the part set aside for HNIs was subscribed by 57 percent Saroja Pharma Industries IPO: Retail investors lent good support to the IPO and subscribed for 18.81 lakh shares, which was 3.65 times their reserved portion, while the part set aside for HNIs was subscribed by 57 percent\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/saroja-pharma-industries-ipo-booked-201-timesday-2_17226191.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Saroja Pharma Industries IPO: Retail investors lent good support to the IPO and subscribed for 18.81 lakh shares, which was 3.65 times their reserved portion, while the part set aside for HNIs was subscribed by 57 percent<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-74534","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2017\/200x200\/p\/pharma_drug_medicine1_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/74534","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=74534"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/74534\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=74534"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=74534"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=74534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}